Michael Steckel
Impact in
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Immunology top 5%
- Immune Response and Inflammation
- interferon and immune responses
- Invertebrate Immune Response Mechanisms
Papers in
-
- RNA modifications and cancer 4
- Cancer therapeutics and mechanisms 3
- Ubiquitin and proteasome pathways 2
- Protein Degradation and Inhibitors 1
- Oncology 4
- Cytokine Signaling Pathways and Interactions 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Nobuyuki Tanaka (1 shared paper)Kunihiro Matsumoto (1 shared paper)Matthew S. Hayden (1 shared paper)Shannon T. Bailey (1 shared paper)Ki‐Young Lee (1 shared paper)Changchun Xiao (1 shared paper)Sankar Ghosh (1 shared paper)P. Nagesh Rao (1 shared paper)
- Journals
- Cancer Research (4 papers)Genes & Development (1 paper)Cell Research (1 paper)Cell Death and Disease (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- GermanySingaporeUnited Kingdom
In The Last Decade
Michael Steckel
14 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Cancer Research 472
- Immunology 464
- Molecular Biology 779
- Oncology 261
- Immunology and Allergy 24
Countries citing papers authored by Michael Steckel
This map shows the geographic impact of Michael Steckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Steckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Steckel more than expected).
Fields of papers citing papers by Michael Steckel
This network shows the impact of papers produced by Michael Steckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Steckel. The network helps show where Michael Steckel may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Steckel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo Hit paper breakdown → | 2005 | 617 |
| 2 | 2012 | 215 | |
| 3 | 2012 | 128 | |
| 4 | 2005 | 106 | |
| 5 | 2019 | 87 | |
| 6 | 2017 | 33 | |
| 7 | 2019 | 27 | |
| 8 | 2015 | 3 | |
| 9 | RNAi as a tool for target discovery in early pharmaceutical research. | 2016 | 3 |
| 10 | 2015 | 2 | |
| 11 | 2012 | 1 | |
| 12 | 2012 | 1 | |
| 13 | 2015 | 1 | |
| 14 | 2018 | 1 |
About Michael Steckel
Michael Steckel is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Organic Chemistry, having authored 14 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Cancer therapeutics and mechanisms (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer-related Molecular Pathways (2 papers), Ubiquitin and proteasome pathways (2 papers), Invertebrate Immune Response Mechanisms (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Cancer Research (472 citations), Immunology (464 citations), Molecular Biology (779 citations), Oncology (261 citations) and Immunology and Allergy (24 citations). Michael Steckel has collaborated with scholars based in Germany, Singapore and United Kingdom. Frequent co-authors include Nobuyuki Tanaka, Kunihiro Matsumoto, Matthew S. Hayden, Shannon T. Bailey, Ki‐Young Lee, Changchun Xiao, Sankar Ghosh, P. Nagesh Rao, Gen Yamada and Shizuo Akira. Their work appears in journals such as Cancer Research, Genes & Development, Cell Research, Cell Death and Disease and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.